Salmedix Inc

Salmedix is an oncology drug development company with a commercial focus on the treatment of hematologic malignancies, or blood cancers.

Launch date

Nov 2000

San Diego California (HQ)

Date	Investors	Amount	Round
Jan 2001	InterWest Partners Versant Ventures Delphi Ventures Alexandria Equities CMEA Ventures	N/A	Series A
Jun 2002	InterWest Partners ProQuest Investments Aberdare Ventures Versant Ventures Alexandria Venture Investments Delphi Ventures Biofrontier Partners GeneChem CMEA Ventures	$27.5m	Series B
Jun 2005*	Cephalon	N/A	Acquisition
Oct 2005	Novo Ventures Cariden Technologies OrbiMed HIG Capital Quilvest Private Equity Covera Ventures	$45.0m	Series C
Total Funding		$72.5m

Recent News about Salmedix Inc